No Data
The Trader: Conagra Took a GLP-1 Hit. Why Its Stock Is Worth a Look. -- Barron's
By Paul R. La Monica Ozempic and other popular injectable GLP-1 drugs aren't just helping dieters shed pounds. They're also leading to share price losses for top food stocks. Take a look at Conagra B
Express News | Mondelez - Notes Were Issued Pursuant to an Indenture, Dated as of March 6, 2015
Express News | Mondelez - Issued an Aggregate Principal Amount of C$650 Mln of CAD-Denominated Senior Notes Due 2031
Cocoa Rises as Near-Term Tightness Overshadows Next Crop Surplus
Cocoa futures rose in New York as markets weigh an ongoing stockpile drawdown against a rosier outlook for next season’s production.
Mondelez (MDLZ) Navigates Hurdles Through Portfolio Strength
Express News | Mondelez : Piper Sandler Cuts Target Price to $76 From $78